Ro Stock
Ro is the healthcare technology company building a patient-centric healthcare system. Ro's vertically integrated primary care platform powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care.
Sign up for SecondMarket™ to view the market and buy or sell Ro Stock
Buy + SellRo Funding
Sign up to gain insights into Ro funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Feb 15, 2022 | Series D | 100.00M | ||
| Mar 05, 2021 | Series D | 500.00M | ||
| Jul 23, 2020 | Series C | 39.04M | ||
| Jul 23, 2020 | Series C | 50.25M | ||
| Jul 23, 2020 | Series C | 33.72M | ||
| Apr 15, 2019 | Series B | 85.54M | ||
| Sep 18, 2018 | Series A | 3.09M | ||
| Sep 18, 2018 | Series A | 39.99M | ||
| Sep 18, 2018 | Series A | 19.95M | ||
| Aug 03, 2017 | Seed | 2.87M |
See Ro Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Ro Stock Valuation + Share Prices
View real-time Tape D™ data on Ro stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Ro Management Team
Director
Tony West
Chief Technology Officer
Todd Levy
Co-Founder, CEO, Director
Zachariah Reitano
Co-Founder, Chief Product Officer, Director
Saman Rahmanian
Director
Rick Heitzmann
CFO
Aaron Susman
Director
Hemant Taneja
Chief Medical Officer
Melynda Barnes
Co-Founder, Director
Rob Schutz
Director
Alexis Ohanian
Ro Major Investors
Altimeter Capital Management LLC
BoxGroup
Dragoneer Investment Group
FirstMark Capital LLC
General Catalyst Partners LLC
Initialized Capital
Seven Seven Six
ShawSpring Partners
SignalFire
Sinai Ventures
Slow Ventures
The Baupost Group
The Chernin Group
The Radcliff Companies
Torch Venture Capital
TQ Ventures
Tusk Ventures
